
Emergent BioSolutions Inc. 0IGA.L
0IGA.L
Emergent BioSolutions Inc. 0IIM.L
Esperion Therapeutics, Inc. 0LOV.L
Verastem, Inc. 0IFK.L
Editas Medicine, Inc. 0J4V.L
Heron Therapeutics, Inc. 0R1D.L
Sangamo Therapeutics, Inc. 0JDK.L
Iovance Biotherapeutics, Inc. 0H8T.L
Aclaris Therapeutics, Inc. 0L85.L
Sorrento Therapeutics, Inc. 0IV3.L
Geron Corporation
Emergent BioSolutions Inc. 0IIM.L
Esperion Therapeutics, Inc. 0LOV.L
Verastem, Inc. 0IFK.L
Editas Medicine, Inc. 0J4V.L
Heron Therapeutics, Inc. 0R1D.L
Sangamo Therapeutics, Inc. 0JDK.L
Iovance Biotherapeutics, Inc. 0H8T.L
Aclaris Therapeutics, Inc. 0L85.L
Sorrento Therapeutics, Inc. 0IV3.L
Geron Corporation
Performance
Periode | 0IGA.L | 0IIM.L | 0LOV.L | 0IFK.L | 0J4V.L | 0R1D.L | 0JDK.L | 0H8T.L | 0L85.L | 0IV3.L |
---|---|---|---|---|---|---|---|---|---|---|
6M | 104.16 % | 171.69 % | 65.40 % | 181.40 % | -31.77 % | -9.16 % | -36.72 % | 69.27 % | 0.00 % | -4.17 % |
YTD | -6.14 % | 18.50 % | 47.50 % | 164.96 % | -19.63 % | -36.29 % | -73.64 % | -24.03 % | 1 120.00 % | -65.15 % |
1Y | 7.12 % | 37.24 % | 203.32 % | 14.87 % | -25.99 % | -26.92 % | -78.67 % | 59.48 % | 408.33 % | -69.59 % |
3Y | -53.90 % | -66.21 % | 101.10 % | -68.97 % | -65.75 % | -85.62 % | -76.77 % | -88.26 % | -99.60 % | -45.71 % |
5Y | -90.25 % | -38.75 % | -69.32 % | -81.73 % | -93.78 % | -88.79 % | -91.30 % | -72.71 % | -99.94 % | -26.88 % |
10Y | -81.63 % | -38.75 % | -77.62 % | -81.73 % | -94.61 % | -88.79 % | -91.30 % | -92.13 % | -99.92 % | -37.38 % |
Depuis le début | -81.63 % | -38.75 % | -77.62 % | -81.73 % | -94.61 % | -88.79 % | -91.30 % | -92.13 % | -99.92 % | -37.38 % |